Shaaban M M, Salah M
Contraception. 1984 Apr;29(4):335-43. doi: 10.1016/0010-7824(84)90067-2.
This report describes the two-year experience of 250 acceptors of NORPLANT implants and 100 TCu-380-Ag IUD acceptors in Assiut, Egypt. The two-year net continuation rate was 67.9 per 100 for implant users and 52.3 per 100 for IUD users. The most important cause for NORPLANT removal was the disruption of menstrual rhythm. However, by the end of the second year, three-quarters of NORPLANT users had monthly menstrual periods and about 60 percent described the amount of blood loss as average, 15 percent as decreased, 15 percent as increased and 10 percent as variable. About 88 percent of the NORPLANT acceptors rated their experience with the contraceptive as good or excellent.
本报告描述了埃及阿斯尤特250名诺普兰皮下埋植剂使用者和100名TCu-380-Ag宫内节育器使用者的两年情况。皮下埋植剂使用者的两年净续用率为每100人67.9人，宫内节育器使用者为每100人52.3人。取出诺普兰皮下埋植剂的最重要原因是月经周期紊乱。然而，到第二年年底，四分之三的皮下埋植剂使用者月经按月来潮，约60%的使用者称失血量正常，15%的使用者称失血量减少，15%的使用者称失血量增加，10%的使用者称失血量不定。约88%的诺普兰皮下埋植剂使用者对其避孕体验的评价为良好或极佳。
